H3U-26988-83664
2 vaccinations
2 coded responses
19 check-ins
1 free-text entry
2 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 532 / WI
- Registered
- 2022-06-27
- Relationship
- Child or adolescent in my care
- Guardian
- UMY-11834-14537
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-27
Registered in v-safe
-
2022-06-27
Dose 1 — Moderna
- 2022-06-27
- 2022-06-28
- 2022-06-29
- 2022-06-30
- 2022-07-01
- 2022-07-03
- 2022-07-06
- 2022-07-11
- 2022-07-20
- 2022-07-25
-
2022-07-26
Dose 2 — Moderna
- 2022-08-01
- 2022-08-02
- 2022-08-09
- 2022-08-18
- 2022-08-23
- 2022-08-30
- 2022-09-06
-
2022-10-25
Survey response — 3 months, dose 2, under 3MedDRA: Pyrexia, Rash, Respiratory tract congestion, Roseola — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: High fever, congestion, rash, roseolaMedDRA releases: 2024-11 · check-in free text available
-
2022-10-25
Report sent to call center — 3 months, dose 2, under 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-10-26
-
2022-10-26
Call successfulParticipant prefers to complete VAERS report online
-
2023-01-24
Survey response — 6 months, dose 2, under 3MedDRA: Ear infection, Irritability, Nasopharyngitis, Respiratory tract congestion, Viral infection — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-01-24
Report sent to call center — 6 months, dose 2, under 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-01-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-27 | Moderna | No |
| 2 | 2022-07-26 | Moderna | No |
Call center
2 call center cases
1 successful · 1 unsuccessful
Free text
Release 12 (Under 3) — 3 months, dose 2, under 3
Symptoms: High fever, congestion, rash, roseola
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ear infection | · | · | ✓ |
| SD | Irritability | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Roseola | · | · | ✓ |
| SD | Viral infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release